サマリー

インターベンショナル・パルモロジーは、呼吸器内科の中でも比較的新しい分野です。インターベンショナル・パルモノロジーは、低侵襲性の内視鏡や経皮的処置などを用いて、喘息、COPD、肺がんなどの肺や胸部の疾患を診断・治療します。

市場分析と洞察。インターベンショナル・パルモロジー治療の世界市場
インターベンショナル・パルモロジー治療の世界市場規模は、2020年のXX百万米ドルから、2021-2027年の間にXX％のCAGRで、2027年にはXX百万米ドルに達すると予測されます。
本レポートは、業界標準の正確な分析と高いデータの整合性により、世界のインターベンショナル・パルモノロジー治療市場で得られる主要な機会を明らかにし、プレイヤーが市場での確固たる地位を獲得するのに役立つよう、見事な試みを行っています。本レポートの購入者は、検証された信頼性の高い市場予測にアクセスすることができ、その中には収益面での世界のインターベンショナル・パルモノロジー治療市場の全体的なサイズも含まれています。
全体として、本レポートは、プレイヤーが競合他社に対して優位に立ち、世界のインターベンショナル・パルモノロジー治療市場で永続的な成功を収めるために利用できる効果的なツールであることが証明されています。本レポートに掲載されているすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界のインターベンショナル・パルモノロジー治療市場を詳細に調査するために、独自の業界最高の調査・分析アプローチを採用しました。

世界のインターベンショナル・パルモノロジー治療の範囲と市場規模
Interventional Pulmonology Treatment市場は、企業別、地域（国）別、タイプ別、アプリケーション別に分類されています。世界のInterventional Pulmonology Treatment市場のプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年の期間で、タイプ別とアプリケーション別の収益と予測に焦点を当てています。

タイプ別セグメント
気管支内視鏡
胸腔鏡（Thoracoscopes
呼吸器系エンドセラピーデバイス
気道ステント
胸膜カテーテル
気管支内バルブ

用途別セグメント
病院
クリニック
その他

地域別
北アメリカ
米国
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
北欧
その他のヨーロッパ諸国
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア諸国
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中近東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他の中東・アフリカ地域

会社別
メドトロニック
ボストン・サイエンティフィック
BD
スミスメディカル
カール・ストルツ
クックメディカル
クララスメディカル
オリンパス
Vygon SA
富士フイルムメディカルシステムズ
リチャード・ウルフ
HOYA株式会社
ELLA-CS
テウオンメディカル
HUGER エンドスコピー機器

ページTOPに戻る

目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Interventional Pulmonology Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Bronchoscopes
1.2.3 Thoracoscopes
1.2.4 Respiratory Endotherapy Devices
1.2.5 Airway Stents
1.2.6 Pleural Catheters
1.2.7 Endobronchial Valves
1.3 Market by Application
1.3.1 Global Interventional Pulmonology Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Interventional Pulmonology Treatment Market Perspective (2016-2027)
2.2 Interventional Pulmonology Treatment Growth Trends by Regions
2.2.1 Interventional Pulmonology Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Interventional Pulmonology Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Interventional Pulmonology Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Interventional Pulmonology Treatment Industry Dynamic
2.3.1 Interventional Pulmonology Treatment Market Trends
2.3.2 Interventional Pulmonology Treatment Market Drivers
2.3.3 Interventional Pulmonology Treatment Market Challenges
2.3.4 Interventional Pulmonology Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Interventional Pulmonology Treatment Players by Revenue
3.1.1 Global Top Interventional Pulmonology Treatment Players by Revenue (2016-2021)
3.1.2 Global Interventional Pulmonology Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Interventional Pulmonology Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Interventional Pulmonology Treatment Revenue
3.4 Global Interventional Pulmonology Treatment Market Concentration Ratio
3.4.1 Global Interventional Pulmonology Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Interventional Pulmonology Treatment Revenue in 2020
3.5 Interventional Pulmonology Treatment Key Players Head office and Area Served
3.6 Key Players Interventional Pulmonology Treatment Product Solution and Service
3.7 Date of Enter into Interventional Pulmonology Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Interventional Pulmonology Treatment Breakdown Data by Type
4.1 Global Interventional Pulmonology Treatment Historic Market Size by Type (2016-2021)
4.2 Global Interventional Pulmonology Treatment Forecasted Market Size by Type (2022-2027)

5 Interventional Pulmonology Treatment Breakdown Data by Application
5.1 Global Interventional Pulmonology Treatment Historic Market Size by Application (2016-2021)
5.2 Global Interventional Pulmonology Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Interventional Pulmonology Treatment Market Size (2016-2027)
6.2 North America Interventional Pulmonology Treatment Market Size by Type
6.2.1 North America Interventional Pulmonology Treatment Market Size by Type (2016-2021)
6.2.2 North America Interventional Pulmonology Treatment Market Size by Type (2022-2027)
6.2.3 North America Interventional Pulmonology Treatment Market Size by Type (2016-2027)
6.3 North America Interventional Pulmonology Treatment Market Size by Application
6.3.1 North America Interventional Pulmonology Treatment Market Size by Application (2016-2021)
6.3.2 North America Interventional Pulmonology Treatment Market Size by Application (2022-2027)
6.3.3 North America Interventional Pulmonology Treatment Market Size by Application (2016-2027)
6.4 North America Interventional Pulmonology Treatment Market Size by Country
6.4.1 North America Interventional Pulmonology Treatment Market Size by Country (2016-2021)
6.4.2 North America Interventional Pulmonology Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Interventional Pulmonology Treatment Market Size (2016-2027)
7.2 Europe Interventional Pulmonology Treatment Market Size by Type
7.2.1 Europe Interventional Pulmonology Treatment Market Size by Type (2016-2021)
7.2.2 Europe Interventional Pulmonology Treatment Market Size by Type (2022-2027)
7.2.3 Europe Interventional Pulmonology Treatment Market Size by Type (2016-2027)
7.3 Europe Interventional Pulmonology Treatment Market Size by Application
7.3.1 Europe Interventional Pulmonology Treatment Market Size by Application (2016-2021)
7.3.2 Europe Interventional Pulmonology Treatment Market Size by Application (2022-2027)
7.3.3 Europe Interventional Pulmonology Treatment Market Size by Application (2016-2027)
7.4 Europe Interventional Pulmonology Treatment Market Size by Country
7.4.1 Europe Interventional Pulmonology Treatment Market Size by Country (2016-2021)
7.4.2 Europe Interventional Pulmonology Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Interventional Pulmonology Treatment Market Size (2016-2027)
8.2 Asia-Pacific Interventional Pulmonology Treatment Market Size by Type
8.2.1 Asia-Pacific Interventional Pulmonology Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Interventional Pulmonology Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Interventional Pulmonology Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Interventional Pulmonology Treatment Market Size by Application
8.3.1 Asia-Pacific Interventional Pulmonology Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Interventional Pulmonology Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Interventional Pulmonology Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Interventional Pulmonology Treatment Market Size by Region
8.4.1 Asia-Pacific Interventional Pulmonology Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Interventional Pulmonology Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Interventional Pulmonology Treatment Market Size (2016-2027)
9.2 Latin America Interventional Pulmonology Treatment Market Size by Type
9.2.1 Latin America Interventional Pulmonology Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Interventional Pulmonology Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Interventional Pulmonology Treatment Market Size by Type (2016-2027)
9.3 Latin America Interventional Pulmonology Treatment Market Size by Application
9.3.1 Latin America Interventional Pulmonology Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Interventional Pulmonology Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Interventional Pulmonology Treatment Market Size by Application (2016-2027)
9.4 Latin America Interventional Pulmonology Treatment Market Size by Country
9.4.1 Latin America Interventional Pulmonology Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Interventional Pulmonology Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Interventional Pulmonology Treatment Market Size (2016-2027)
10.2 Middle East & Africa Interventional Pulmonology Treatment Market Size by Type
10.2.1 Middle East & Africa Interventional Pulmonology Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Interventional Pulmonology Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Interventional Pulmonology Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Interventional Pulmonology Treatment Market Size by Application
10.3.1 Middle East & Africa Interventional Pulmonology Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Interventional Pulmonology Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Interventional Pulmonology Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Interventional Pulmonology Treatment Market Size by Country
10.4.1 Middle East & Africa Interventional Pulmonology Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Interventional Pulmonology Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Details
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Interventional Pulmonology Treatment Introduction
11.1.4 Medtronic Revenue in Interventional Pulmonology Treatment Business (2016-2021)
11.1.5 Medtronic Recent Development
11.2 Boston Scientific
11.2.1 Boston Scientific Company Details
11.2.2 Boston Scientific Business Overview
11.2.3 Boston Scientific Interventional Pulmonology Treatment Introduction
11.2.4 Boston Scientific Revenue in Interventional Pulmonology Treatment Business (2016-2021)
11.2.5 Boston Scientific Recent Development
11.3 BD
11.3.1 BD Company Details
11.3.2 BD Business Overview
11.3.3 BD Interventional Pulmonology Treatment Introduction
11.3.4 BD Revenue in Interventional Pulmonology Treatment Business (2016-2021)
11.3.5 BD Recent Development
11.4 Smiths Medical
11.4.1 Smiths Medical Company Details
11.4.2 Smiths Medical Business Overview
11.4.3 Smiths Medical Interventional Pulmonology Treatment Introduction
11.4.4 Smiths Medical Revenue in Interventional Pulmonology Treatment Business (2016-2021)
11.4.5 Smiths Medical Recent Development
11.5 Karl Storz
11.5.1 Karl Storz Company Details
11.5.2 Karl Storz Business Overview
11.5.3 Karl Storz Interventional Pulmonology Treatment Introduction
11.5.4 Karl Storz Revenue in Interventional Pulmonology Treatment Business (2016-2021)
11.5.5 Karl Storz Recent Development
11.6 Cook Medical
11.6.1 Cook Medical Company Details
11.6.2 Cook Medical Business Overview
11.6.3 Cook Medical Interventional Pulmonology Treatment Introduction
11.6.4 Cook Medical Revenue in Interventional Pulmonology Treatment Business (2016-2021)
11.6.5 Cook Medical Recent Development
11.7 Clarus Medical
11.7.1 Clarus Medical Company Details
11.7.2 Clarus Medical Business Overview
11.7.3 Clarus Medical Interventional Pulmonology Treatment Introduction
11.7.4 Clarus Medical Revenue in Interventional Pulmonology Treatment Business (2016-2021)
11.7.5 Clarus Medical Recent Development
11.8 Olympus
11.8.1 Olympus Company Details
11.8.2 Olympus Business Overview
11.8.3 Olympus Interventional Pulmonology Treatment Introduction
11.8.4 Olympus Revenue in Interventional Pulmonology Treatment Business (2016-2021)
11.8.5 Olympus Recent Development
11.9 Vygon SA
11.9.1 Vygon SA Company Details
11.9.2 Vygon SA Business Overview
11.9.3 Vygon SA Interventional Pulmonology Treatment Introduction
11.9.4 Vygon SA Revenue in Interventional Pulmonology Treatment Business (2016-2021)
11.9.5 Vygon SA Recent Development
11.10 FUJIFILM Medical Systems
11.10.1 FUJIFILM Medical Systems Company Details
11.10.2 FUJIFILM Medical Systems Business Overview
11.10.3 FUJIFILM Medical Systems Interventional Pulmonology Treatment Introduction
11.10.4 FUJIFILM Medical Systems Revenue in Interventional Pulmonology Treatment Business (2016-2021)
11.10.5 FUJIFILM Medical Systems Recent Development
11.11 Richard Wolf
11.11.1 Richard Wolf Company Details
11.11.2 Richard Wolf Business Overview
11.11.3 Richard Wolf Interventional Pulmonology Treatment Introduction
11.11.4 Richard Wolf Revenue in Interventional Pulmonology Treatment Business (2016-2021)
11.11.5 Richard Wolf Recent Development
11.12 HOYA Corporation
11.12.1 HOYA Corporation Company Details
11.12.2 HOYA Corporation Business Overview
11.12.3 HOYA Corporation Interventional Pulmonology Treatment Introduction
11.12.4 HOYA Corporation Revenue in Interventional Pulmonology Treatment Business (2016-2021)
11.12.5 HOYA Corporation Recent Development
11.13 ELLA-CS
11.13.1 ELLA-CS Company Details
11.13.2 ELLA-CS Business Overview
11.13.3 ELLA-CS Interventional Pulmonology Treatment Introduction
11.13.4 ELLA-CS Revenue in Interventional Pulmonology Treatment Business (2016-2021)
11.13.5 ELLA-CS Recent Development
11.14 Taewoong Medical
11.14.1 Taewoong Medical Company Details
11.14.2 Taewoong Medical Business Overview
11.14.3 Taewoong Medical Interventional Pulmonology Treatment Introduction
11.14.4 Taewoong Medical Revenue in Interventional Pulmonology Treatment Business (2016-2021)
11.14.5 Taewoong Medical Recent Development
11.15 HUGER Endoscopy Instruments
11.15.1 HUGER Endoscopy Instruments Company Details
11.15.2 HUGER Endoscopy Instruments Business Overview
11.15.3 HUGER Endoscopy Instruments Interventional Pulmonology Treatment Introduction
11.15.4 HUGER Endoscopy Instruments Revenue in Interventional Pulmonology Treatment Business (2016-2021)
11.15.5 HUGER Endoscopy Instruments Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details